Result description
To combat the pandemic of the coronavirus disease (COVID-19), numerous governments try to prescreen potential cases.
Symptoma is a digital health assistant that can differentiate more than 20,000 diseases with an accuracy of more than 90%.
We tested the accuracy of Symptoma to identify COVID-19 using a set of diverse clinical cases combined with case reports of COVID-19.
We showed that Symptoma can accurately distinguish COVID-19 in 96.32% of clinical cases. When considering only COVID-19 symptoms and risk factors, Symptoma identified 100% of those infected when presented with only three signs. Lastly, we showed that Symptoma’s accuracy far exceeds that of simple “yes-no” questionnaires widely available online.
In summary, Symptoma provides unparalleled accuracy in systematically identifying cases of COVID-19 while also considering over 20,000 other diseases. Furthermore, Symptoma allows free text input, furthered with disease-specific follow up questions, in 36 languages. Combined, these results and accessibility give Symptoma the potential to be a key tool in the global fight against COVID-19.
Symptoma is freely available at symptoma.com.
Addressing target audiences and expressing needs
- To raise awareness and possibly influence policy
- Grants and Subsidies
- Other blended financing
- Collaboration
- Venture Capital
- Other type of Investment
- Public or private funding institutions
- EU and Member State Policy-makers
- International Organisations (ex. OECD, FAO, UN, etc.)
- Research and Technology Organisations
- Private Investors
R&D, Technology and Innovation aspects
Result submitted to Horizon Results Platform by SYMPTOMA GMBH
